Source link : https://newshealth.biz/health-news/drugmaker-refuses-fdas-request-to-pull-gene-therapy-tied-to-patient-deaths/
(MedPage Today) — Sarepta Therapeutics will continue to ship its gene therapy delandistrogene moxeparvovec (Elevidys) to ambulant patients with Duchenne muscular dystrophy, despite the FDA’s request to halt distribution, the company stated late… Source link : https://www.medpagetoday.com/neurology/generalneurology/116598 Author : Publish date : 2025-07-21 16:57:00 Copyright for syndicated content belongs to the linked Source.
The post Drugmaker Refuses FDA’s Request to Pull Gene Therapy Tied to Patient Deaths first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-21 16:57:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8